| abstract |
Patients susceptible to or suffering from conditions and abnormalities such as central nervous system abnormalities are given to patients in need of treatment with pyridyloxyalkylamine, phenoxyalkylamine, pyridylthioalkylamine, and phenylthioalkyl of formula (I) Treated by administering aryloxyalkylamines and arylthioalkylamines including amines:n n n n n n n n Wherein X is nitrogen or carbon and X 'is individually nitrogen, N-O or carbon. |